View |
|
DR-XY40804
|
Guaifenesin + Salbutamol
|
Asmalex
|
50 mg / 1 mg per 5 mL
|
Syrup
|
Expectorant/Bronchodilator
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
07 April 2022
|
03 April 2027
|
View |
|
DR-XY40805
|
Guiafenesin + Salbutamol
|
Asmalex
|
100 mg / 2 mg
|
Capsule
|
Expectorant/Selective Beta-2-adrenoreceptor Antagonist
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
08 March 2022
|
03 April 2027
|
View |
|
DR-XY40806
|
Tamsulosin Hydrochloride
|
None
|
200mg
|
Capsule
|
-
|
UNILAB, Inc.
|
Philippines
|
-
|
11 May 2020
|
03 April 2025
|
View |
|
DR-XY40807
|
Tamsulosin Hydrochloride
|
Prozelax
|
400 mcg
|
Capsule
|
Alpha-Adrenoceptor Antagonist
|
UNILAB, Inc.
|
Philippines
|
Initial (Correction)
|
07 February 2023
|
14 October 2027
|
View |
|
DR-XY40810
|
Fexofenadine Hydrochloride
|
Fenofex
|
120 mg
|
Film-Coated Tablet
|
Antihistamine
|
Geofman Pharmaceuticals
|
Pakistan
|
Automatic Renewal
|
03 March 2022
|
03 April 2027
|
View |
|
DR-XY40811
|
Fexofenadine Hydrochloride
|
Fenofex
|
60 mg
|
Film-Coated Tablet
|
Antihistamines
|
Geofman Pharmaceuticals
|
Pakistan
|
Automatic Renewal
|
14 March 2022
|
03 April 2027
|
View |
|
DR-XY40812
|
Clonidine (As Hydrochloride)
|
Cataclon
|
75 mcg
|
Tablet
|
Alpha-2 Adrenoceptor Agonist
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
30 January 2023
|
03 April 2028
|
View |
|
DR-XY40826
|
Metropolol Succinate
|
Ometpro-100
|
95 mg
|
Extended-Release Tablet
|
Beta-Adrenoreceptor Blocker
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
16 February 2022
|
16 April 2027
|
View |
|
DR-XY40832
|
Verapamil Hydrochloride
|
Isoptin SR
|
240mg
|
Sustained-release Tablet
|
Calcium Channel Blocker
|
AbbVie Deutschland GmbH & Co. KG
|
Germany
|
Automatic Renewal
|
28 February 2022
|
18 April 2027
|
View |
|
DR-XY40836
|
Cetirizine Dihydrochloride
|
Rinozine
|
10 mg
|
Film-Coated Tablet
|
Antihistamine
|
Pharmasant Laboratories Co., Ltd.
|
Thailand
|
Automatic Renewal
|
02 March 2022
|
19 April 2027
|
View |
|
DR-XY40837
|
Tarceva
|
Erlotinib
|
150 mg
|
Film-Coated Tablet
|
Antineoplastic Agent (Protein Kinase Inhibitor)
|
Roche S.p.A.
|
Italy
|
Renewal
|
19 April 2022
|
20 April 2027
|
View |
|
DR-XY40838
|
Erlotinib
|
Tarceva
|
100 mg
|
Film-Coated Tablet
|
Antineoplastic Agent (Protein Kinase Inhibitor)
|
Roche S.p.A.
|
Italy
|
Automatic Renewal
|
16 March 2022
|
20 April 2027
|
View |
|
DR-XY40842
|
Glucose + Amino Acids + Electrolytes + Lipid
|
Smofkabiven Peripheral
|
Formulation: Glicose 13%: Each mL contains: Glucose monohydrate-143mg Corresponding to glucose, anhydrous-130mg Lipid Emulsion 20% Each ml contains: Soya-bean oil, refined-60mg Triglycerides, medium chain-60mg Olive oil, refined-50mg Fish oil, rich in omega 3-acids-30mg Amino Acid solution 10% with electrolytes: Each ml contains. L-Alanine-14mg L-Arginine-12mg L-Proline-11.2mg Glycine (Amino acetic acid)-11mg L-Lysine acetate-9.3mg
Corresponding to L-Lysine-6.6mg L-Leucine-7.4mg L-Serine-6.5mg L-Valine-6.2mg Sodium acetate trihydrate-5.62mg
Corresponding to sodium acetate anhydrous-3.4mg
L-Phenylalanine Potassium chloride-4.48mg L-Threonine-4.4mg L-Methionine-4.3mg Sodium glycerophosphate, anhydrous-4.18mg L-Histidine-3mg Magnesium sulfate heptahydrate-2.47mg
corresponding to magnesium sulfate, anhydrous-1.2mg L-Tryptophan-2mg L-Taurine-1mg Calcium chlonde dehydrate-740mg
corresponding to calçium chloride, anhydrous-560mg L-Tyrosine-400mg Zinc sulfate heptahydrate-23mg
corresponding to zinc sulfate, anhydrous-12.9mg
Electrolytes-5.1 mg Acetate-66 mmol/L Sodium-25 mmol/L Chloride-22 mmol/L Potassium-19 mmol/L Phosphate-8.2 mmoVL Magnesium-3.2 mmoll Sulfate-3.2 mmol/L Calcium-1.6 mmol/L
Zinc-20 umol/L
Osmolarity approx. 950 mosmol/kg water Osmolarity approx. 850 mosmol/L pH (after mixing) approx...5.6
|
Emulsion For IV Infusion
|
Parenteral Nutrition
|
Fresenius Kabi AB
|
Sweden
|
Automatic Renewal (Reconstruction)
|
31 July 2024
|
06 April 2026
|
View |
|
DR-XY40848
|
Meloxicam
|
Osteoflam
|
7.5 mg
|
Tablet
|
Non-Steroidal Anti-inflammatory Drug
|
Bal Pharma Limited
|
India
|
Automatic Renewal
|
07 March 2022
|
02 May 2027
|
View |
|
DR-XY40849
|
Meloxicam
|
Osteoflam
|
15 mg
|
Tablet
|
Non-Steroidal Anti-inflammatory Drug (NSAID)
|
Bal Pharma Limited
|
India
|
Automatic Renewal
|
09 March 2022
|
02 May 2027
|
View |
|
DR-XY40850
|
Rivaroxaban
|
Xarelto
|
15 mg
|
Film-Coated Tablet
|
-
|
Bayer AG
|
Germany
|
-
|
26 March 2020
|
25 April 2025
|
View |
|
DR-XY40851
|
Rivaroxaban
|
Xarelto
|
20 mg
|
Film-Coated Tablet
|
-
|
Bayer AG
|
Germany
|
-
|
13 April 2020
|
25 April 2025
|
View |
|
DR-XY40852
|
Cefixime (as trihydrate)
|
Vamocef
|
20 mg/mL
|
Powder For Suspension (Oral Drops)
|
Antibacterials
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
30 May 2022
|
03 May 2027
|
View |
|
DR-XY40858
|
Domperidone
|
Degut
|
5mg/5mL
|
Suspension
|
-
|
Delta Pharma Limited
|
Bangladesh
|
-
|
24 February 2022
|
10 May 2025
|
View |
|
DR-XY40860
|
Clonidine (as Hydrochloride)
|
Alphapres
|
75 mcg
|
Tablet
|
Antihypertensive (Alpha-2 Adrenoceptor Agonist)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
29 March 2022
|
10 May 2027
|